Molecular Mechanisms in the Pathogenesis of Idiopathic Nephrotic Syndrome

This comprehensive book reviews our current state of knowledge about the pathogenesis of idiopathic nephrotic syndrome (INS), which comprises a heterogeneous group of diseases with distinct histological characteristics, such as minimal-change nephrotic syndrome (MCNS), focal segmental glomeruloscler...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Collectivité auteur: SpringerLink (Online service)
Autres auteurs: Kaneko, Kazunari (Éditeur intellectuel)
Format: Électronique eBook
Langue:Inglés
Publié: Tokyo : Springer Japan : Imprint: Springer, 2016.
Édition:1st ed. 2016.
Sujets:
Nephrology.
Urology.
Medicine-Research.
Biology-Research.
Biomedical Research.
Accès en ligne:Texto Completo
Table des matières:
  • Part 1. Introduction
  • 1. History of Research on Pathogenesis of Idiopathic Nephrotic Syndrome
  • Part 2. Minimal-change nephrotic syndrome (MCNS)
  • 2. Hemopexin in Minimal Change Nephrotic Syndrome
  • 3. Angiopoietin-like-4 (Angptl4) in MCNS
  • 4. Co-stimulatory molecule CD80 (B7.1) in MCNS
  • 5. Energy and Mammalian target of rapamycin complex 1 (mTORC1) in minimal change nephrotic syndrome
  • 6. The role of c-mip in the pathogenesis of Minimal Change Nephrotic Syndrome
  • 7. REGULATORY T-CELLS AND OXIDATIVE STRESS IN MINIMAL CHANGE NEPHROPATHY
  • 8. CYTOKINES AS ACTIVE FACTORS IN MINIMAL CHANGE NEPHROTIC SYNDROME
  • Part 3. Focal segmental glomerulosclerosis (FSGS)
  • 9. Soluble urokinase-type plasminogen activator receptor (suPAR) in Focal Segmental Glomerulosclerosis
  • 10. CYTOKINES AS ACTIVE FACTORS IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS
  • Part 4. Idiopathic Membranous Nephropathy (IMN)
  • 11. M-Type Phospholipase A2 Receptor (PLA2R) and Thrombospondin Type-1 Domain-Containing 7A (THSD7A) in Membranous Nephropathy
  • 12. Cationic Bovine Serum Albumin as Cause of Membranous Nephropathy: From Mice to Men
  • Part 5. Treatment in Idiopathic Nephrotic Syndrome
  • 13. Podocytes as a direct target of drugs used in Idiopathic Nephrotic Syndrome.

Documents similaires